Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

FUJIFILM Pharmaceuticals U.S.A., Inc.FUJIFILM Pharmaceuticals U.S.A., Inc.
VS
CatalentCatalent
FUJIFILM Pharmaceuticals U.S.A., Inc.

FUJIFILM Pharmaceuticals U.S.A., Inc.

1 Broadway, Cambridge, 02142, US

Last Update: 24/01/2026

View Profile

About FUJIFILM Pharmaceuticals U.S.A., Inc. Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug devel...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:8
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Catalent

Catalent

101 E Kennedy Blvd, Tampa, Florida, US, 33602

Last Update: 04/04/2026

View Profile
Between 750 and 799
https://www.catalent.com
782/1000Fair

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping peopl...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,604
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
FUJIFILM Pharmaceuticals U.S.A., Inc.

FUJIFILM Pharmaceuticals U.S.A., Inc.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Catalent

Catalent

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for FUJIFILM Pharmaceuticals U.S.A., Inc. in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Catalent in 2026.

Incidents

Incident History - FUJIFILM Pharmaceuticals U.S.A., Inc. (X = Date, Y = Severity)

FUJIFILM Pharmaceuticals U.S.A., Inc. cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Catalent (X = Date, Y = Severity)

Catalent cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
FUJIFILM Pharmaceuticals U.S.A., Inc.

FUJIFILM Pharmaceuticals U.S.A., Inc.

Incidents
No explicit notable incidents reported.
Catalent

Catalent

Incidents
No explicit notable incidents reported.

FAQ

Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has the best AI Cybersecurity Score ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has experienced more cyber incidents in the past ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has experienced more cyber incidents this year ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has experienced at least one ransomware attack ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has experienced at least one data breach ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has experienced at least one targeted cyberattack ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has experienced at least one vulnerability ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one holds the most compliance certifications ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one holds the fewest compliance certifications ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has the most subsidiaries ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Catalent company, which one has the largest number of employees ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Catalent, which company holds both SOC 2 Type 1 certifications ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Catalent, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - FUJIFILM Pharmaceuticals U.S.A., Inc. or Catalent ?
Which company is PCI DSS compliant - FUJIFILM Pharmaceuticals U.S.A., Inc. or Catalent ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Catalent, which company complies with HIPAA regulations for healthcare data ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Catalent, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-19961
SUMMARY

A vulnerability was detected in Edimax EW-7478APC 1.04. Affected is the function formWlSiteSurvey of the file /goform/formWlSiteSurvey. Performing a manipulation of the argument selSSID results in buffer overflow. The attack is possible to be carried out remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-19960
SUMMARY

A security vulnerability has been detected in Edimax EW-7478APC 1.04. This impacts the function formWlbasic of the file /goform/formWlbasic. Such manipulation of the argument rootAPmac leads to command injection. The attack can be executed remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 7.4)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 7.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:L/SI:L/SA:L/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.7
EXPLOITABILITY
3.1
CVE-2026-19959
SUMMARY

A weakness has been identified in Edimax EW-7478APC 1.04. This affects the function formWanTcpipSetup of the file /goform/formWanTcpipSetup. This manipulation of the argument pppUserName causes stack-based buffer overflow. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-19958
SUMMARY

A security flaw has been discovered in iatsiuk pptr-mcp up to 0.2.7. The impacted element is the function executeCode of the file src/vm-executor.ts of the component execute Tool. The manipulation results in code injection. The attack may be launched remotely. The exploit has been released to the public and may be used for attacks. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-19957
SUMMARY

A vulnerability was identified in graphlit graphlit-mcp-server 1.0.1. This affects the function fetch of the file src/tools.ts of the component ssrf-test Endpoint. Such manipulation of the argument url leads to server-side request forgery. The attack may be launched remotely. The exploit is publicly available and might be used. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8